Literature DB >> 24584455

New 5-ylidene rhodanine derivatives based on the dispacamide A model.

Solene Guiheneuf1, Ludovic Paquin, François Carreaux, Emilie Durieu, Thierry Roisnel, Laurent Meijer, Jean-Pierre Bazureau.   

Abstract

A practical approach for the preparation of (5Z) 5-ylidene rhodanine derivatives bearing the (4,5-dihalogeno-pyrrol-2-yl)carbamoyl fragment of dispacamide A is reported. The new compounds were obtained in good yields (19-88 %) by Knoevenagel condensation according to a solution-phase microwave dielectric heating protocol in the presence of organic bases (piperidine, TEA, and AcONa) from a set of N-substituted rhodanines 2(a-i). The ten synthetic products 3(a-j) have been synthesized with a Z-geometry about their exocyclic double bond and the structure of one of these compounds (3) was confirmed by a single X-ray diffraction analysis. The new (5Z) 5-ylidene rhodanine derivatives 3(a-j) were tested against eight protein kinases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24584455     DOI: 10.1007/s11030-014-9509-7

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  34 in total

1.  Identification of inhibitors for UDP-galactopyranose mutase.

Authors:  Michelle Soltero-Higgin; Erin E Carlson; John H Phillips; Laura L Kiessling
Journal:  J Am Chem Soc       Date:  2004-09-01       Impact factor: 15.419

Review 2.  Development of tau aggregation inhibitors for Alzheimer's disease.

Authors:  Bruno Bulic; Marcus Pickhardt; Boris Schmidt; Eva-Maria Mandelkow; Herbert Waldmann; Eckhard Mandelkow
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

3.  Small-molecule inhibitors of islet amyloid polypeptide fibril formation.

Authors:  Rajesh Mishra; Bruno Bulic; Daniel Sellin; Suman Jha; Herbert Waldmann; Roland Winter
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

4.  Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial.

Authors:  Nigishi Hotta; Yasuo Akanuma; Ryuzo Kawamori; Kempei Matsuoka; Yoshitomo Oka; Motoaki Shichiri; Takayoshi Toyota; Mitsuyoshi Nakashima; Isao Yoshimura; Nobuo Sakamoto; Yukio Shigeta
Journal:  Diabetes Care       Date:  2006-07       Impact factor: 19.112

5.  Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors.

Authors:  Raveendra Dayam; Tino Sanchez; Omoshile Clement; Robert Shoemaker; Shizuko Sei; Nouri Neamati
Journal:  J Med Chem       Date:  2005-01-13       Impact factor: 7.446

6.  Chemical synthesis and biological validation of immobilized protein kinase inhibitory Leucettines.

Authors:  Guillaume Burgy; Tania Tahtouh; Emilie Durieu; Béatrice Foll-Josselin; Emmanuelle Limanton; Laurent Meijer; François Carreaux; Jean-Pierre Bazureau
Journal:  Eur J Med Chem       Date:  2013-02-06       Impact factor: 6.514

7.  Synthesis and biological evaluation of thiazolidine-2,4-dione and 2,4-thione derivatives as inhibitors of translation initiation.

Authors:  Han Chen; Yun-Hua Fan; Amarnath Natarajan; Yuhong Guo; Julia Iyasere; Fred Harbinski; Lia Luus; William Christ; Huseyin Aktas; Jose A Halperin
Journal:  Bioorg Med Chem Lett       Date:  2004-11-01       Impact factor: 2.823

8.  Aldose reductase structures: implications for mechanism and inhibition.

Authors:  O El-Kabbani; F Ruiz; C Darmanin; R P-T Chung
Journal:  Cell Mol Life Sci       Date:  2004-04       Impact factor: 9.261

9.  Rhodanine derivatives as selective protease inhibitors against bacterial toxins.

Authors:  Sherida L Johnson; Li-Hsing Chen; Rebecca Harbach; Mojgan Sabet; Alexei Savinov; Naomi J H Cotton; Alex Strongin; Donald Guiney; Maurizio Pellecchia
Journal:  Chem Biol Drug Des       Date:  2008-01-19       Impact factor: 2.817

10.  Synthesis and characterization of (Z)-5-arylmethylidene-rhodanines with photosynthesis-inhibiting properties.

Authors:  Veronika Opletalova; Jan Dolezel; Katarina Kralova; Matus Pesko; Jiri Kunes; Josef Jampilek
Journal:  Molecules       Date:  2011-06-22       Impact factor: 4.411

View more
  1 in total

Review 1.  5-Ene-4-thiazolidinones - An efficient tool in medicinal chemistry.

Authors:  Danylo Kaminskyy; Anna Kryshchyshyn; Roman Lesyk
Journal:  Eur J Med Chem       Date:  2017-09-20       Impact factor: 6.514

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.